FIC Capital’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | $13.6M | Sell |
909,437
-50,901
| -5% | -$764K | 5.2% | 3 |
|
|
2017
Q2 | $8.45M | Buy |
960,338
+19,429
| +2% | +$171K | 3.48% | 4 |
|
|
2017
Q1 | $4.89M | Buy |
940,909
+65,625
| +7% | +$341K | 2.17% | 9 |
|
|
2016
Q4 | $2.67M | Buy |
875,284
+15,445
| +2% | +$47.1K | 1.34% | 28 |
|
|
2016
Q3 | $3.98M | Sell |
859,839
-2,650
| -0.3% | -$12.3K | 1.79% | 16 |
|
|
2016
Q2 | $4.99M | Sell |
862,489
-55
| -0% | -$318 | 2.36% | 7 |
|
|
2016
Q1 | $5.22M | Sell |
862,544
-7,670
| -0.9% | -$46.4K | 2.53% | 8 |
|
|
2015
Q4 | $7.95M | Sell |
870,214
-10,815
| -1% | -$98.7K | 3.52% | 4 |
|
|
2015
Q3 | $4.97M | Buy |
881,029
+93,500
| +12% | +$527K | 2.33% | 14 |
|
|
2015
Q2 | $8.73M | Buy |
787,529
+4,050
| +0.5% | +$44.9K | 3.47% | 3 |
|
|
2015
Q1 | $12.3M | Sell |
783,479
-1,050
| -0.1% | -$16.5K | 4.67% | 2 |
|
|
2014
Q4 | $11.9M | Buy |
784,529
+25,375
| +3% | +$386K | 4.62% | 2 |
|
|
2014
Q3 | $8.19M | Buy |
759,154
+23,105
| +3% | +$249K | 3.27% | 3 |
|
|
2014
Q2 | $11.2M | Sell |
736,049
-260
| -0% | -$3.97K | 4.38% | 1 |
|
|
2014
Q1 | $13.3M | Buy |
736,309
+26,495
| +4% | +$479K | 5.44% | 1 |
|
|
2013
Q4 | $9.86M | Buy |
709,814
+34,275
| +5% | +$476K | 4.42% | 1 |
|
|
2013
Q3 | $7.09M | Sell |
675,539
-557
| -0.1% | -$5.84K | 3.6% | 3 |
|
|
2013
Q2 | $5.28M | Buy |
+676,096
| New | +$5.28M | 3.38% | 2 |
|